Nyxoah SA NYXH

Healthcare SIC 3841 - Surgical & Medical Instruments & Apparatus NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical and Medical Instrument Manufacturing derived Nasdaq

Last close —

Market cap —

52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—

P/E—

P/FCF—

EV/EBITDA—

Dividend yield—

Diluted EPS—

Annual financial statements

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-035161.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)

Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity

Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks

No annual figures to plot for this company yet.

Others in SIC 3841

Ticker	Company	Market cap	P/E	Revenue growth
SYK	STRYKER CORP	$117.81B	36.6x	11.2%
MMM	3M CO	$89.46B	28.9x	1.5%
BSX	BOSTON SCIENTIFIC CORP	$66.22B	23.6x	19.9%
BDX	BECTON DICKINSON & CO	$54.18B	34.2x	8.2%
RMD	RESMED INC	$36.48B	24.2x	9.9%
DXCM	DEXCOM INC	$29.41B	37.3x	15.6%
MDLN	Medline Inc.	$29.20B	—	11.5%
WST	WEST PHARMACEUTICAL SERVICES INC	$27.60B	57.8x	6.3%